Citation:Taieb J, Zaanan A, Le Malicot K, Julié C, Blons H, Mineur L, et al 2016

From Cancer Guidelines Wiki

Citation


Taieb J, Zaanan A, Le Malicot K, Julié C, Blons H, Mineur L, et al. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial. JAMA Oncol 2016 Jan 14;:1-11 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26768652.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingBen Lee-Batescompleted
Optimal molecular profilingVictoria Freemancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling